씨티씨바이오

060590KOSDAQ

52.0 / 100

Reference Date: 2026-10-23

Financial Score22.5 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 12.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

CTC Bio operates in the animal and human pharmaceutical sectors, leveraging core technologies such as microbial fermentation, drug coating, and DDS to develop diverse products. Its key revenue drivers include award-winning products like CTCZYME and ODF films, while the company actively manages foreign exchange risks to strengthen its global competitiveness.

Number of Employees

237people

Average Salary

46.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

19.71Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.90Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

4.55Industry Average 8.002.5Point

Below industry avg

Debt Ratio

27.63Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲135.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.0% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 2,700Won52-week high 5,50052-week low 2,700

1-month return1.0Point

1m -12.05% (falling)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0